Key Insights

Highlights

Treatment Research

2 treatments under study, led by Balanced Salt Solution

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

2Total
Phase 4 (2)

Trial Status

Terminated1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Balanced Salt Solution2
  • Proparacaine Hydrochloride Ophthalmic Solution Usp 052

Active Sponsors

  • Corewell Health East1
  • Louisiana State University Health Sciences Center in New Orleans1

Top Investigators

Related Conditions

  • Dacryocystitis2
  • Epiphora2

Activity Timeline